Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals

被引：5
作者：
Singh, Manisha [1 ]
Singh, Surinder P. [2 ]
Yadav, Deepshikha [2 ,3 ,4 ]
Agarwal, Mugdha [1 ]
Agarwal, Shriya [1 ]
Agarwal, Vinayak [1 ]
Swargiary, Geeta [1 ]
Srivastava, Sahil [1 ]
Tyagi, Sakshi [1 ]
Kaur, Ramneek [5 ]
Mani, Shalini [1 ]
机构：
[1] Jaypee Inst Informat Technol JILT Noida, Dept Biotechnol, Noida, UP, India
[2] CSIR Natl Phys Lab, Bhartiya Nirdeshak Dravya Div, New Delhi, India
[3] CSIR Natl Phys Lab, Physicomech Metrol Div, New Delhi, India
[4] Acad Sci & Innovat Res AcSIR, Ghaziabad, UP, India
[5] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
来源：
CURRENT GENE THERAPY | 2021年 / 21卷 / 01期
关键词：
Gene therapy; neurodegenerative diseases; viral vectors; nonviral vectors; Alzheimer disease; Parkinson disease; schizophrenia retroviruses; SPINAL-MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; PARKINSONS-DISEASE; IN-VIVO; ALZHEIMERS-DISEASE; PROLONGS SURVIVAL; MULTIPLE-SCLEROSIS; MUTANT HUNTINGTIN;
D O I：
10.2174/1566523220999200817164907
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
The technique of gene therapy, ever since its advent nearly fifty years ago, has been utilized by scientists as a potential treatment option for various disorders. This review discusses some of the major neurodegenerative diseases (NDDs) like Alzheimer's disease (AD), Parkinson's Disease (PD), Motor neuron diseases (MND), Spinal Muscular Atrophy (SMA), Huntington's Disease (HD), Multiple Sclerosis (MS), etc. and their underlying genetic mechanisms along with the role that gene therapy can play in combating them. The pathogenesis and the molecular mechanisms specifying the altered gene expression of each of these NDDs have also been discussed in elaboration. The use of gene therapy vectors can prove to be an effective tool in the field of curative modern medicine for the generations to come. Therefore, consistent efforts and progressive research towards its implementation can provide us with powerful treatment options for disease conditions that have so far been considered as incurable.
引用
收藏
页码：23 / 42
页数：20
相关论文
共 166 条
  • [51] ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
    Gaj, Thomas
    Gersbach, Charles A.
    Barbas, Carlos F., III
    [J]. TRENDS IN BIOTECHNOLOGY, 2013, 31 (07) : 397 - 405
  • [52] Mechanisms of neurodegeneration in Huntington's disease
    Gil, Joana M.
    Rego, Ana Cristina
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (11) : 2803 - 2820
  • [53] Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
    Gilkes, J. A.
    Bloom, M. D.
    Heldermon, C. D.
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2016, 6 : 48 - 54
  • [54] Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease
    Gillingwater, T. H.
    Wishart, T. M.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 (04) : 320 - 334
  • [55] Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery
    Golzio, M
    Mazzolini, L
    Moller, P
    Rols, MP
    Teissié, J
    [J]. GENE THERAPY, 2005, 12 (03) : 246 - 251
  • [56] Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854
  • [57] Gouze-Decaris E, 2001, ARTHRITIS RES S1, V3, P34, DOI DOI 10.1186/AR361
  • [58] Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy
    Gray-Edwards, Heather L.
    Brunson, Brandon L.
    Holland, Merrilee
    Hespel, Adrien-Maxence
    Bradbury, Allison M.
    McCurdy, Victoria J.
    Beadlescomb, Patricia M.
    Randle, Ashley N.
    Salibi, Nouha
    Denney, Thomas S.
    Beyers, Ronald J.
    Johnson, Aime K.
    Voyles, Meredith L.
    Montgomery, Ronald D.
    Wilson, Diane U.
    Hudson, Judith A.
    Cox, Nancy R.
    Baker, Henry J.
    Sena-Esteves, Miguel
    Martin, Douglas R.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2015, 116 (1-2) : 80 - 87
  • [59] Gene Therapy for Leber Hereditary Optic Neuropathy
    Guy, John
    Feuer, William J.
    Davis, Janet L.
    Porciatti, Vittorio
    Gonzalez, Phillip J.
    Koilkonda, Rajeshwari D.
    Yuan, Huijun
    Hauswirth, William W.
    Lam, Byron L.
    [J]. OPHTHALMOLOGY, 2017, 124 (11) : 1621 - 1634
  • [60] Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
    Hauswirth, William W.
    Aleman, Tomas S.
    Kaushal, Shalesh
    Cideciyan, Artur V.
    Schwartz, Sharon B.
    Wang, Lili
    Conlon, Thomas J.
    Boye, Sanford L.
    Flotte, Terence R.
    Byrne, Barry J.
    Jacobson, Samuel G.
    [J]. HUMAN GENE THERAPY, 2008, 19 (10) : 979 - 990
12345678910